The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
23886684 |
36 |
Synthesis of quaternarya-amino acid-based arginase inhibitors via the Ugi reaction. |
Institutes For Pharmaceutical Discovery |
23453840 |
32 |
2-Substituted-2-amino-6-boronohexanoic acids as arginase inhibitors. |
Institutes For Pharmaceutical Discovery |
23472952 |
35 |
Discovery of (R)-2-amino-6-borono-2-(2-(piperidin-1-yl)ethyl)hexanoic acid and congeners as highly potent inhibitors of human arginases I and II for treatment of myocardial reperfusion injury. |
Institutes For Pharmaceutical Discovery |
21875805 |
5 |
Synthesis of a new trifluoromethylketone analogue of l-arginine and contrasting inhibitory activity against human arginase I and histone deacetylase 8. |
Drexel University |
21728378 |
9 |
Binding ofa,a-disubstituted amino acids to arginase suggests new avenues for inhibitor design. |
Drexel University |
20441173 |
19 |
2-aminoimidazole amino acids as inhibitors of the binuclear manganese metalloenzyme human arginase I. |
University of Pennsylvania |
32292567 |
40 |
Discovery and Optimization of Rationally Designed Bicyclic Inhibitors of Human Arginase to Enhance Cancer Immunotherapy. |
Merck |
30300845 |
43 |
1-(2-Hydroxybenzoyl)-thiosemicarbazides are promising antimicrobial agents targeting d-alanine-d-alanine ligase in bacterio. |
Universit£ |
32292546 |
16 |
Discovery and Pharmacokinetics of Sulfamides and Guanidines as Potent Human Arginase 1 Inhibitors. |
Oncoarendi Therapeutics |
31408339 |
28 |
Discovery of |
New England Discovery Partners |
29914772 |
4 |
Rational design of novel irreversible inhibitors for human arginase. |
Brown University |
17441705 |
28 |
Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV. |
Takeda Pharmaceutical |